Ameritas Advisory Services
APYX icon

Ameritas Advisory Services’s Apyx Medical APYX Stock Holding History

Ameritas Advisory Services’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$214 – 980
2025
Q3 		$214 Hold
100
– – ﹤0.01% 2103
2025
Q2 		$225 Buy
+100
New +$141 ﹤0.01% 2749

Other funds holding APYX

Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $211M AUM 58.81% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Horizon Kinetics Asset Management
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

Ameritas Advisory Services's APYX Position: Q4 2025 in Review

Ameritas Advisory Services sold out of Apyx Medical (APYX) in Q4 2025, closing a stake of 100 shares — an estimated $214 sold.

Ameritas Advisory Services first reported a position in APYX in Q2 2025 and held it in 2 quarters. The position peaked at $225 in Q2 2025. 59 funds tracked by Wall St. Rank hold APYX as of Q4 2025.

  • Ameritas Advisory Services reported no remaining Apyx Medical position as of Q4 2025 after selling out during the quarter.
  • Ameritas Advisory Services sold 100 Apyx Medical shares in Q4 2025, an estimated $214.
  • Ameritas Advisory Services first reported a position in Apyx Medical in Q2 2025 and held it in 2 quarters.
  • Ameritas Advisory Services's Apyx Medical position peaked at $225 in Q2 2025.
  • 59 funds tracked by Wall St. Rank held Apyx Medical as of Q4 2025.

Based on Ameritas Advisory Services's 13F filing for Q4 2025, filed 4 Feb 2026.